Primary study · included by 1 review
The Effect of Statins on the Incidence and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.
Symvoulidis 2023 · Symvoulidis Panagiotis, Tsioutis Constantinos, Zamboglou Constantinos, et al. · Current oncology (Toronto, Ont.) · 2023
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Risk of bladder cancer Statins vs Controls | RR 1.32 [0.76, 2.30] | 6 studies · 1166668 participants | Low |
Risk of bladder cancer Statins vs Placebo | RR 0.89 [0.68, 1.16] | 4 studies · 27849 participants | Moderate |
Risk of bladder cancer With spironolactone vs Without spironolactone | RR 0.89 [0.74, 1.06] | 3 studies · 254392 participants | Very low |
1 including review in total.